harnoor's blog

Medical Aesthetics Market Trends, Opportunities, Key Players, Gro...

During our research, we identified over 200 medical aesthetic companies offering various medical aesthetic products and / or devices.

The global medical aesthetics marketsize is estimated to grow from USD 38 billion in 2024 to USD 102 billion by 2035, representing a CAGR of 9.5% during the forecast period till 2035.

Maximum number of companies are engaged in offering facial aesthetic products and / or devices. These products and devices are widely used for treating various skin abnormalities, such as scars, laxity, wrinkles, moles, pigmentation, and liver spots (age spots). This is followed by companies offering body contouring devices that can help in redefining, recreating and reshaping the body. Additionally, 38% of the players are providing various laser hair removal and IPL hair removal machines that can provide painless and long-lasting results compared to traditional hair removal approaches, such as shaving, threading, and waxing. This is followed by 24% and 15% of firms which are offering tattoo removal and nail treatment devices, respectively. Further, 14% of companies are providing breast augementation solutions, including breast aesthetic devices and breast implants.

Majority of the companies are providing facial aesthetic devices. It is worth highlighting that these facial aesthetic devices are non invasive in nature and don’t involve any surgery, making them cost-effective as well. Examples of firms offering facial aesthetic devices include (in alphabetical order) Cynosure, InMode and Lutronic. In addition, 62 players are engaged in offering dermal fillers, which are extensively used for eliminating wrinkles, smoothening facial lines and volumizing the face. Moreover, the treatment can be done in even less than 30 minutes with minimal recovery time. This is followed by 25% of the firms that are manufacturing microneedling devices that can help in boosting collagen production to achieve firm, smooth, and even tone skin.

It is interesting to note that maximum number of medical aesthetic companies were established during the time period, 2001-2020. This is indicative of the continuous emergence of players into the medical aesthetics market over the past decades, reflecting a stable and enticing industry landscape.

Company Competitiveness Analysis – Evaluating the overall potential of Medical Aesthetic Companies

This chapter provides a detailed competitiveness analysis of various medical aesthetic companies identified during our research, which are based in North America, Europe, Asia-Pacific, and the Rest of the World. The companies considered in this analysis were scored based on several relevant parameters, such as company strength of the company offering different products and devices (in terms of number of years of experience of a company), and the portfolio strength (in terms of type of offering, type of product and / or device offered and type of procedure). Insights obtained from the analysis have been presented in the form of three-dimensional bubble charts, with company strength on the x-axis, portfolio strength on the y-axis and number of end user served is indicated by the size of the bubble (z-axis).

The growth in partnership activity in recent years reflects the rising interest in this sector. During our research, we came across several partnerships and collaborations that have been established between several stakeholders engaged in the field of medical aesthetics, during the time period 2018-2023.

As can be observed in the figure, the trend of partnerships in this domain has remained consistent between 2020 and 2022. However, it is interesting to note that partnerships have increased at a CAGR of 14%, during the period, 2018-2022. The increase was mainly attributed to the increased consciousness amongst people regarding their cosmetic appearance during the COVID-19 pandemic. It is noteworthy that the majority of agreements signed in 2022 were focused on the distribution of various medical aesthetic products and devices, across the globe. Additionally, in 2023 (till August) a total of seven agreements were signed between the stakeholders, including acquisitions / mergers, supply and product / technology integration, and supply agreements.

Players based in Asia-Pacific and rest of the world have signed the maximum number of collaborations (35.9%), of which 20.5% are intracontinental agreements and 15.4% are intercontinental agreements. In North America, majority of the deals were inked with the intracontinental players; of which players based in the US, emerged as the most active players having inked most of the deals. Further, players in Europe account for approximately 31% of the total medical aesthetic solution providers.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/medical-aesthetics-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]

Website: https://www.rootsanalysis.com/

Yesterday, 02:29
0 comments
Tags: medical aesthetics market, medical aesthetics market size, medical aesthetics

Big Data in Healthcare Market Trends, Opportunities, Key Players,...

The current market landscape features the presence of close to 405 big data service providers in healthcare. The majority of the big data in healthcare service providers offer both data warehouses and data lakes as storage and management solution for healthcare big data. Further, the maximum of the service providers caters to the needs of healthcare providers, including hospitals, and clinics, followed by companies that offer big data in healthcare services for contract research organizations and pharmaceutical companies.

The global big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% during the forecast period till 2035.

Notably, the maximum number of companies are engaged in offering big data analytics as a part of their big data services. This indicates significant demand for data analysis and insights across various healthcare segments. This is followed by companies that provide big data management services to effectively organize and store both unstructured and structured healthcare big data.

Most of the services providers are offering operational management services for big data in healthcare. It is worth noting that operational management in healthcare involves optimizing processes and improving efficiency in areas, including resource allocation, workflow management, and supply chain management.

The big data in healthcare market is anticipated to grow at a healthy pace, till 2035. The different driving factors for the big data in healthcare market include the growing volume of healthcare data arising from various sources including patient health records, medical imaging, genomic sequencing, pharmaceutical research, wearables, and medical devices. Our estimates suggest that currently, the maximum revenue generated in this domain is likely to be driven by the hardware segment; this trend is likely to change in the foreseen future, as software is expected to lead the market in future.

Based on primary and secondary research, our estimates suggest that the hardware segment of the big data in healthcare market is likely to be driven by storage devices. This can be attributed to the increasing volume of data generated in the healthcare industry, including electronic health records and medical imaging.

In terms of type of service segment, the big data in healthcare market is likely to be driven by diagnostic analytics. Furthermore, most of the market share is captured by electronic health records, followed by revenue cycle management software, and practice management software. This trend is unlikely to change in the foreseeable future. Presently, our estimates suggest that initiatives focused on operational management are likely to drive the current big data in healthcare market. This can be attributed to the fact that operational data is one of the largest sources of data in the healthcare industry and given the complexity of the healthcare industry. It is important to highlight that low-middle income countries are expected to grow with the fastest CAGR in the near future.

According to our primary and secondary research presently, the majority of the big data market in healthcare is occupied by hospitals, followed by health insurance agencies. Further, this trend is unlikely to change in the foreseeable future as well. It is worth highlighting that the big data in healthcare market is dominated by North America and this trend is unlikely to change in the foreseeable future. On the other hand, the big data in healthcare market in Asia is expected to grow at a fastest pace, during the forecast period.